Update: November, 14, 1996

2019 (IP Disclosures to ASU):A New Oncolytic Virus Platform to Treat Metastatic Cancers with Triple Transgene Armed Myxoma Virus (D20-007) Provisional IP filed July 19, 2019 A New Method to Improve Yield of Oncolytic Myxoma Virus for GMP Manufacture (Addendum 2019) ................
................